New Framework Agreement on Supply and Pricing of Medicines (FASPM) 2026–2029

A new Framework Agreement on the Supply and Pricing of Medicines between the HSE and the Irish Pharmaceutical Healthcare Association (IPHA) took effect from 1 January 2026 and runs to 31 December 2029. Key provisions include: Horizon scanning: pharmaceutical companies must notify the HSE of new medicines 12–18 months in advance of expected launch. Rebate […]

Dr Robert Peel Appointed SMC Chair from 1 April 2026

Dr Robert Peel, Consultant Nephrologist at Raigmore Hospital, Inverness, became Chair of the Scottish Medicines Consortium on 1 April 2026, succeeding Professor Scott Muir. Dr Peel previously chaired the SMC New Drugs Committee. As a nephrologist who has spent decades prescribing high-cost medicines against defined eligibility criteria, he brings relevant clinical experience of the governance […]